Cite
HARVARD Citation
Shakespeare, T. et al. (2006). Phase II study of the American Brachytherapy Society guidelines for the use of high–dose rate brachytherapy in the treatment of cervical carcinoma: is 45–50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high–dose rate brachytherapy tolerable?. International journal of gynecological cancer. 16 (1), pp. 277-282. [Online].